AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Harzulin 80mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Glanto Pharmaceuticals

Salt Composition

Gliclazide (80mg) + Metformin (500mg)

Overview Harzulin 80mg/500mg Tablet SR

DiabetaComb 80mg/500mg Extended-Release Tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by regulating blood glucose. DiabetaComb 80mg/500mg Extended-Release Tablets should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication is one component of a comprehensive diabetes management plan, incorporating a balanced diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Common side effects include hypoglycemia (low blood sugar), characterized by sweating, dizziness, headache, and trembling; constipation; and vomiting. Maintain regular mealtimes and carry a readily available fast-acting glucose source, like sugary snacks or juice, to counteract hypoglycemia. Alcohol consumption elevates hypoglycemia risk and should be limited. Other possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or lactating women should consult their doctor prior to use. Regular blood sugar checks and potential blood tests to monitor blood cell counts and liver function will be advised by your doctor.

Uses of Harzulin 80mg/500mg Tablet SR

Adult-onset diabetes

Major Benefits of Harzulin 80mg/500mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Harzulin 80mg/500mg Tablet SR whole; do not chew, crush, or divide the tablet. Administer this medicine with a meal.

Common Side effects of Harzulin 80mg/500mg Tablet SR:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Dizziness
  • Diarrhea
  • Upper respiratory tract infection
  • Nausea
  • Flatulence
  • Constipation

How to use Harzulin 80mg/500mg Tablet SR:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the Harzulin 80mg/500mg Tablet SR whole; avoid chewing, crushing, or fracturing it. It should be taken with a meal.

How Harzulin 80mg/500mg Tablet SR works:

The extended-release tablet, Harzulin 80mg/500mg, contains a dual-action formulation of gliclazide and metformin, both used in diabetes management.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Harzulin 80mg/500mg SR tablets with alcohol is not recommended due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Harzulin 80mg/500mg sustained-release tablets during pregnancy poses a confirmed risk to the fetus. While generally contraindicated, a physician might exceptionally prescribe it in critical circumstances where potential benefits outweigh the known hazards. Always seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Prolonged-release Harzulin 80mg/500mg tablets are likely unsuitable for breastfeeding mothers. Scant clinical evidence indicates potential drug transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Impaired driving is possible with abnormally high or low blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Harzulin 80mg/500mg SR tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates Harzulin 80mg/500mg SR tablet use. Physician consultation is essential. Regular kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Harzulin 80mg/500mg SR tablets cautiously, potentially requiring dosage modification. A physician's consultation is recommended. For those with mild to moderate hepatic dysfunction, initiation at a reduced dose is typical; however, its use is contraindicated in cases of severe liver disease.

What if you forget to take Harzulin 80mg/500mg Tablet SR :

Should you forget to take your Harzulin 80mg/500mg SR Tablet, ingest it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed tablet and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Harzulin 80mg/500mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Harzulin 80mg/500mg Tablet SR

Harzulin 80mg/500mg SR tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Harzulin 80mg/500mg SR tablets may cause common side effects such as hypoglycemia, taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Harzulin 80mg/500mg SR tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry glucose tablets, honey, or fruit juice.
Harzulin 80mg/500mg Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare side effect is preventable by avoiding use in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, stop taking Harzulin 80mg/500mg Tablet SR and seek immediate medical attention.
Prolonged use of Harzulin 80mg/500mg SR tablets can lead to vitamin B12 deficiency by interfering with its stomach absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 intake is recommended by some researchers.
Harzulin 80mg/500mg SR tablets are contraindicated in patients with allergies to any ingredient or excipient. They should also be avoided in those with moderate to severe kidney disease or metabolic acidosis, including diabetic ketoacidosis.
Combining Harzulin 80mg/500mg SR tablets and alcohol is unsafe. Alcohol can worsen low blood sugar and raise the risk of lactic acidosis.
Harzulin 80mg/500mg SR tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood sugar control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. Harzulin is not suitable for type 1 diabetes.
Harzulin 80mg/500mg SR tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Harzulin 80mg/500mg SR Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice for emergencies.
Harzulin 80mg/500mg Tablet SR can cause lactic acidosis, a serious medical emergency characterized by high blood lactic acid levels (also known as MALA, or Metformin-associated lactic acidosis). This rare side effect is less likely in patients without kidney disease, who are not elderly, and who don't consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Harzulin 80mg/500mg Tablet SR and seek immediate medical attention.
Prolonged use of Harzulin 80mg/500mg SR tablets can lead to vitamin B12 deficiency by interfering with its stomach absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, supplemental vitamin B12 is recommended at least annually.
Harzulin 80mg/500mg SR tablets are contraindicated in patients with allergies to any ingredient or excipient, and in those with moderate to severe kidney disease or metabolic acidosis (including diabetic ketoacidosis).
Consuming alcohol while taking Harzulin 80mg/500mg SR tablets is unsafe. It can worsen low blood sugar and raise the risk of lactic acidosis.
Harzulin 80mg/500mg Table...
77
MRP 89
13% off